Bakoš Matija, Dilber Daniel, Jazbec Anamarija, Svaguša Tomo, Potkonjak Ana-Meyra, Braovac Duje, Đurić Željko, Radeljak Andrea, Lončar Vrančić Ana, Vraneš Hrvoje, Galić Slobodan, Novak Milivoj, Prkacin Ingrid
Department of Pediatrics, University Hospital Centre Zagreb, Zagreb, Croatia.
School of Medicine, University of Zagreb, Zagreb, Croatia.
Front Cardiovasc Med. 2024 May 20;11:1391434. doi: 10.3389/fcvm.2024.1391434. eCollection 2024.
In children, congenital heart defects represent the primary cause of increased serum troponin I. The elimination process of cardiac troponin I from the bloodstream and the factors influencing this process remain unknown. The objective of this study was to explore the role of troponin I as an indicator of cardiac damage in children both in serum and urine, a concept previously investigated in adults.
Our prospective study involved 70 children under 24 months of age. The first group underwent ventricular septal defect repair, while the second group involved children who had undergone partial cavopulmonary anastomosis. For these groups, urine and serum troponin I were assessed on four occasions. The third group, consisting of healthy children, underwent a single measurement of urine troponin I.
Serum troponin I values exhibited an expected elevation in the early postoperative period, followed by a return to lower levels. Significantly higher concentrations of serum troponin I were observed in the first group of children ( < 0.05). A positive correlation was found between troponin I in the first three measurements and cardiopulmonary bypass and aortic cross-clamping time. There was no discernible increase in urine troponin I directly related to myocardial damage; troponin I couldn't be detected in most urine samples.
The inability to detect troponin I in urine remains unexplained. Potential explanatory factors may include the isoelectric point of troponin I, elevated urinary concentrations of salts and urea, variations in urine acidity (different pH levels), and a relatively low protein concentration in urine.
在儿童中,先天性心脏缺陷是血清肌钙蛋白I升高的主要原因。心肌肌钙蛋白I从血液中的清除过程以及影响该过程的因素尚不清楚。本研究的目的是探讨肌钙蛋白I作为儿童心脏损伤指标在血清和尿液中的作用,这一概念此前已在成人中进行过研究。
我们的前瞻性研究纳入了70名24个月以下的儿童。第一组接受室间隔缺损修复,第二组包括接受部分腔肺吻合术的儿童。对这些组在四个时间点评估尿液和血清肌钙蛋白I。第三组由健康儿童组成,对其进行单次尿液肌钙蛋白I测量。
血清肌钙蛋白I值在术后早期出现预期的升高,随后恢复到较低水平。在第一组儿童中观察到血清肌钙蛋白I浓度显著更高(<0.05)。在前三次测量中,肌钙蛋白I与体外循环和主动脉阻断时间呈正相关。尿液肌钙蛋白I没有与心肌损伤直接相关的明显升高;大多数尿液样本中检测不到肌钙蛋白I。
无法在尿液中检测到肌钙蛋白I的原因尚不清楚。潜在的解释因素可能包括肌钙蛋白I的等电点、尿液中盐和尿素浓度升高、尿液酸度变化(不同的pH值)以及尿液中相对较低的蛋白质浓度。